Home › Calculator › CNTB Dividend Calculator 2026
CNTB Dividend DRIP Calculator 2026
79.68% YieldHealthcareConnect Biopharma Holdings Limited · NASDAQ
Price: $2.51 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CNTB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CNTB snowball 📈
$10,000 in CNTB → $3.51M in 10 years · $129,628.48/month
About Connect Biopharma Holdings Limited (CNTB) — Dividend Analysis 2026
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
Compare CNTB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CNTB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CNTB position with:
🌍 CNTB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CNTB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 79.68% | 76.88% | $7,968 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 67.73% | 64.93% | $6,773 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 63.74% | 60.94% | $6,374 / yr |
| 🇬🇧 UK ISA | 0% | 79.68% | 76.88% | $7,968 / yr |
| 🇬🇧 UK Taxable | 8.75% | 72.71% | 69.91% | $7,271 / yr |
| 🇨🇦 TFSA | 0% | 79.68% | 76.88% | $7,968 / yr |
| 🇨🇦 CA Taxable | 25% | 59.76% | 56.96% | $5,976 / yr |
| 🇦🇺 Super (pension) | 15% | 67.73% | 64.93% | $6,773 / yr |
| 🇦🇺 AU Taxable | 30% | 55.78% | 52.98% | $5,578 / yr |
| 🇩🇪 DE Taxable | 26.375% | 58.66% | 55.86% | $5,866 / yr |
| 🇫🇷 FR Taxable | 30% | 55.78% | 52.98% | $5,578 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CNTB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CNTB Dividend Payment Schedule
CNTB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CNTB vs Healthcare Benchmarks
How CNTB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CNTB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CNTB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-30 | 3,738 | — | — | ||
| A-Award | 2026-06-30 | 6,718 | — | — | ||
| Buy | 2026-05-29 | 150,000 | $2.48 | $371.6K | ||
| A-Award | 2026-03-31 | 2,816 | — | — | ||
| A-Award | 2026-03-31 | 5,061 | — | — | ||
| Buy | 2026-03-31 | 1,160,000 | $3.45 | $4.00M | ||
| Other | 2026-03-16 | 1,772,489 | $1.77 | $3.14M | ||
| Other | 2026-03-16 | 409,355 | $0.97 | $397.1K | ||
| Other | 2026-03-16 | 400,000 | $2.69 | $1.08M | ||
| Other | 2026-03-16 | 2,658,734 | $1.77 | $4.71M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-05-29
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CNTB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Connect Biopharma Holdings Limited (CNTB) is currently trading at $2.51, 89% below its 52-week high. The current dividend yield is 79.68% based on an annual payout of $2.00 per share.
CNTB (Connect Biopharma Holdings Limited) — 79.68% Dividend Yield Analysis
Connect Biopharma Holdings Limited (CNTB) is a healthcare stock currently trading at $2.51 with a dividend yield of 79.68%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (79.68%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CNTB News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.